A Safety and Efficacy Extension Study of ONO-4641 (MSC2430913A) in Patients With Relapsing-Remitting Multiple Sclerosis
| Status: | Terminated |
|---|---|
| Conditions: | Neurology, Neurology, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 4/21/2016 |
| Start Date: | October 2010 |
| End Date: | December 2014 |
The objective of this active-drug Extension Study is to evaluate the continuing safety and
efficacy of ONO-4641 (MSC2430913A) in patients with relapsing-remitting multiple sclerosis
(RRMS) in patients who have completed an initial 26-week study (ONO-4641POU006).
efficacy of ONO-4641 (MSC2430913A) in patients with relapsing-remitting multiple sclerosis
(RRMS) in patients who have completed an initial 26-week study (ONO-4641POU006).
Inclusion Criteria:
- Completed 26 weeks of double-blind phase of Study ONO-4641POU006.
Exclusion Criteria:
- Presence of any dermatological abnormalities during Study ONO-4641POU006 that could
increase the risk of the patient developing a skin cancer.
We found this trial at
21
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials